Skip to main content

Table 3 Pre-treatment genitourinary morbidity and genitourinary acute and late toxicity

From: Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking

   Pre-Tx Acute† Late‡ Last late§
Toxicity Grade n (%) n (%) n (%) n (%)
Dysuria 0 36 (92) 20 (51) 35 (90) 38 (97)
  1 3 (8) 13 (33) 4 (10) 1 (3)
  2 0 5 (13) 0 0
  3 0 1 (3) 0 0
Incontinence 0 34 (87) 33 (84) 34 (87) 37 (94)
  1 4 (10) 5 (13) 4 (10) 1 (3)
  2 1 (3) 1 (3) 1 (3) 1 (3)
Retention 0 20 (51) 16 (41) 23 (59) 34 (86)
  1 13 (33) 9 (23) 11 (28) 3 (8)
  2 5 (13) 12 (31) 4 (10) 1 (3)
  3 1 (3) 2 (5) 1 (3) 1 (3)
Frequency/urgency 0 23 (59) 6 (15) 17 (44) 23 (59)
  1 13 (33) 16 (41) 15 (38) 14 (36)
  2 2 (5) 15 (39) 7 (18) 2 (5)
  3 1 (3) 2 (5) 0 0
Hematuria 0 39 (100) 39 (100) 36 (92) 37 (95)
  1 0 0 1 (3) 2 (5)
  2 0 0 2 (5) 0
Highest GU* 0 15 (39) 1 (3) 11 (28) 19 (49)
  1 14 (36) 13 (33) 16 (41) 13 (33)
  2 8 (20) 22 (56) 11 (28) 6 (15)
  3 2 (5) 3 (8) 1 (3) 1 (3)
  1. Abbreviations: Pre-Tx = pre-treatment; * The highest toxicity in a patient was counted as a single event; † During therapy and until 3 months after completion; ‡ maximal late toxicity > 3 months after completion of therapy; § Incidence of late toxicity at last follow-up visit